MCI-INI-3
MCI-INI-3 is a selective competitive inhibitor of human ALDH1A3 (with a Ki value of 0.55 μM for ALDH1A3 and a Ki value of 78.2 μM for ALDH1A1) . MCIINI-3 inhibits the biosynthesis of retinoic acid and reduces the viability of GSC-83 and GSC-326 glioblastoma cells[1].
Product Specifications
CAS Number
1011366-31-6
UNSPSC
12352005
Target
Aldehyde Dehydrogenase (ALDH)
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
99.23
Solubility
DMSO : 6.67 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=CC(C2=CC3=C(OCO3)C=C2)=NC4=CC(C5=CC=CC=C5)=NN41)OC
Molecular Formula
C21H15N3O4
Molecular Weight
373.36
References & Citations
[1]Jianfeng Li, et al. A specific inhibitor of ALDH1A3 regulates retinoic acid biosynthesis in glioma stem cells. Commun Biol. 2021 Dec 21;4 (1) :1420.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ALDH1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH031829 20 µg
Recombinant Human C2/Complement Component 2 Protein (Fc Tag)
Sign In for Pricing
View Details 
BNC403793-500 1x 500 µL
Erythropoietin (EPO) (Marker of Placentation Disorders) (EPO/3793R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
HA722631B 100 µL
Human IL-31 Recombinant Rabbit monoclonal Antibody
Sign In for Pricing
View Details 